HomeNewsTrendsHealthBlack Fungus | AIIMS issues guidelines for early detection, prevention of mucormycosis

Black Fungus | AIIMS issues guidelines for early detection, prevention of mucormycosis

The guidelines call for strict control and monitoring of blood sugar in diabetics and warn against self-medication with steroids, antibiotics or antifungal drugs.

May 20, 2021 / 16:12 IST
Story continues below Advertisement
Mucormycosis (known as black fungus), a rare life-threatening infection that’s being reported in some COVID-19 patients. (Image: News18 Creative)
Mucormycosis (known as black fungus), a rare life-threatening infection that’s being reported in some COVID-19 patients. (Image: News18 Creative)

The All India Institute of Medical Sciences (AIIMS) in New Delhi has released a new set of guidelines for early detection and prevention of black fungus infection, or mucormycosis, among coronavirus patients, the latest challenge facing the country’s already overwhelmed healthcare infrastructure.

The second coronavirus wave has led to a spike in the black fungus infection, which can be fatal, especially among diabetics recovering from COVID-19. Several states, including Rajasthan and Telangana, have reported multiple cases of black fungus infection and declared it an epidemic.  It has killed 90 people in Maharashtra alone.

Story continues below Advertisement

Doctors have blamed the “irrational use” of steroids, which can exacerbate diabetes, for the disease that affects the brain, lungs and sinuses.

Pharma firms scramble to boost production of antifungal jab Amphotericin B as Black Fungus cases rise

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show